CDXS | tickerfilter.com

Fundamental analysis

12%

Profitability 8%

Dept financing 12%

Liquidity 75%

Performance 0%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

3.10%

1 Month

-13.38%

3 Months

-48.22%

6 Months

-27.41%

1 Year

-19.93%

2 Year

-42.47%

Key data

Stock price

$2.33

P/E Ratio

0.00

DAY RANGE

$2.25 - $2.37

EPS

-$0.89

52 WEEK RANGE

$1.90 - $6.08

52 WEEK CHANGE

-$25.08

MARKET CAP

350.156 M

YIELD

N/A

SHARES OUTSTANDING

70.927 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

05-01-2025

BETA

2.04

PUBLIC FLOAT

AVERAGE 10 VOLUME

$441,561

AVERAGE 30 VOLUME

$878,572

Company detail

CEO: Stephen G. Dilly
Region: US
Website: codexis.com
Employees: 250
IPO year: 2010

Issue type: Common Stock
Market: XNAS
Industry: Chemicals/Industrial Organic Chemicals
Sector: Manufacturing

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company also provides biocatalyst screening and protein engineering services. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe.

CDXS - CODEXIS, INC.